Basics Larimar Therapeutics, Inc. Common Stock IPO Date: July 1, 2014 Sector: Healthcare Industry: Biotech Market Cap: $337.23M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.84% Avg Daily Range (30 D): $0.14 | 3.79% Avg Daily Range (90 D): $0.13 | 4.43% Institutional Daily Volume Avg Daily Volume: .14M Avg Daily Volume (30 D): 1.51M Avg Daily Volume (90 D): 1.26M Trade Size Avg Trade Size (Sh.): 117 Avg Trade Size (Sh.) (30 D): 139 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 171 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $1.07M Avg Inst. Trade (90 D): $1.17M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.95M Avg Closing Trade (30 D): $1.2M Avg Closing Trade (90 D): $1.13M Avg Closing Volume: 304.42K     News Aug 14, 2025 @ 11:33 AM Larimar Beats Q2 Loss Estimates Source: Na Jul 31, 2025 @ 8:15 PM Larimar Therapeutics Announces Closing of Underwri... Source: Globe Newswire Jul 30, 2025 @ 3:50 AM Larimar Therapeutics Announces Pricing of Underwri... Source: Larimar Therapeutics, Inc. Jul 29, 2025 @ 8:01 PM Larimar Therapeutics Announces Proposed Underwritt... Source: Globe Newswire Sep 19, 2024 @ 11:00 AM Larimar Therapeutics Announces Three Poster Presen... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.57 $-.41 $-.46 Diluted EPS $-1.57 $-.41 $-.46 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -99.79M $ -26.18M $ -29.28M Operating Income / Loss $ -108.54M $ -27.79M $ -31.19M Cost of Revenue $ $ $ Net Cash Flow $ .17M $ M $ M PE Ratio